Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii

The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that infection with the parasite Toxoplasma gondii may contribute to the symptoms of schizophrenia in some individuals. We investigated commonly used antipsychotic and mood stabilizing medications for their ability to inhibit the replication of this organism. We employed a system for testing compounds for in vitro activity against T. gondii. Human fibroblasts (HFF) were treated with test compounds and then exposed to Toxoplasma that has been genetically modified to express cytoplasmic beta-galactosidase. Inhibition by the drugs was determined by spectrophotometric analysis of colorimetric reactions. We tested 12 neuroleptic compounds and found that of these, the antipsychotic haloperidol and the mood stabilizer valproic acid most effectively inhibit Toxoplasma growth in vitro. Valproic acid inhibited the parasite at a concentration below that found in the cerebrospinal fluid and blood of individuals being treated with this medication and displayed synergistic activity with haloperidol and with trimethoprim, an antibiotic commonly used to treat Toxoplasma infections.Several medications used to treat schizophrenia and bipolar disorder have the ability to inhibit the in vitro replication of T. gondii.

[1]  R. Yolken,et al.  Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Fairlamb,et al.  Trypanosoma Cruzi trypanothione reductase is inactivated by peroxidase-generated phenothiazine cationic radicals , 2001, Free radical research.

[3]  R. Yolken,et al.  Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1 , 1997, Schizophrenia Research.

[4]  S. Koizumi,et al.  Inhibition by antipsychotic drugs of L-type Ca2+ channel current in PC12 cells. , 1996, European journal of pharmacology.

[5]  J. Flegr,et al.  Influence of chronic toxoplasmosis on some human personality factors. , 1994, Folia parasitologica.

[6]  J. Kristiansen,et al.  The susceptibility of Plasmodium falciparum in vitro to chlorpromazine and the stereo-isomeric compounds cis(Z)- and trans(E)-clopenthixol. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.

[7]  C. Johannessen,et al.  Mechanisms of action of valproate: a commentatory , 2000, Neurochemistry International.

[8]  J. Boothroyd,et al.  Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in vitro , 1997, Antimicrobial agents and chemotherapy.

[9]  S. Zotter,et al.  Abrogation of infectivity of mouse mammary tumor virus by reserpine. , 1982, Experimental pathology.

[10]  Ying-Chieh Wang,et al.  Association analysis of polymorphism in the promoter region of the α2a-adrenoceptor gene with schizophrenia and clozapine response , 2001, Schizophrenia Research.

[11]  P. Gehr,et al.  Trypanocidal action of neuroleptic phenothiazines in Trypanosoma brucei. , 1983, Molecular and biochemical parasitology.

[12]  J. Lieb.  Remission of recurrent herpes infection during therapy with lithium. , 1979, The New England journal of medicine.

[13]  V. Wunderlich,et al.  Lytic action of neurotropic drugs on retroviruses in vitro. , 1980, European journal of cancer.

[14]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[15]  T. Crow,et al.  The effects of psychotropic drugs on synthesis of DNA and the infectivity of herpes simplex virus , 1986, Biological Psychiatry.

[16]  L. Harper,et al.  The effect of lithium chloride on the replication ofHerpes simplex virus , 2005, Medical Microbiology and Immunology.

[17]  Ethanol and acetaldehyde elevate intracellular [Ca2+] and stimulate microneme discharge in Toxoplasma gondii. , 1999 .

[18]  J. Calabrese,et al.  Clinical Studies on the Use of Lamotrigine in Bipolar Disorder , 1998, Neuropsychobiology.

[19]  E. Torrey.  Stalking the schizovirus. , 1988, Schizophrenia bulletin.

[20]  J. Amsterdam,et al.  A possible antiviral action of lithium carbonate in herpes simplex virus infections , 1990, Biological Psychiatry.

[21]  W. Kramer.  Frontiers of neurological diagnosis in acquired toxoplasmosis. , 1966, Psychiatria, neurologia, neurochirurgia.

[22]  E. Hewlett,et al.  Antileishmanial activity of chlorpromazine , 1984, Antimicrobial Agents and Chemotherapy.

[23]  Ladee Ga.  Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. , 1966 .

[24]  A. Fairlamb,et al.  Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures. , 1992, The Biochemical journal.

[25]  J. Simiand,et al.  Mechanism of anticonvulsant action of valproate , 1982, Progress in neurobiology.

[26]  Sheng-Nan Wu,et al.  Characterization of Inhibition by Risperidone of the Inwardly Rectifying K+ Current in Pituitary GH3 Cells , 2000, Neuropsychopharmacology.

[27]  G. Rutter,et al.  Inhibition of measles virus budding by phenothiazines. , 1983, Virology.

[28]  J. Amsterdam,et al.  Rates of flu-like infection in patients with affective illness. , 1998, Journal of affective disorders.

[29]  Chang Tw.  Letter: Suppression of herpetic recurrence by chlorpromazine. , 1975 .

[30]  J. Kristiansen,et al.  Effect of selected neuroleptic agents and stereo-isomeric analogues on virus and eukaryotic cells. , 1991, Pharmacology & toxicology.

[31]  F. Roberts,et al.  The psychiatric complications of toxoplasmosis. , 1959, Lancet.

[32]  A. Nesburn,et al.  Evaluation of lithium as an inhibitory agent of herpes simplex virus in cell cultures and during reactivation of latent infection in rabbits , 1984, Antimicrobial Agents and Chemotherapy.

[33]  S. Kapur,et al.  Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.

[34]  J. Kristiansen,et al.  Inhibition of HIV replication by neuroleptic agents and their potential use in HIV infected patients with AIDS related dementia. , 2000, International journal of antimicrobial agents.

[35]  P. Ehrlich,et al.  Über die Wirkung des Methylenblau bei Malaria , 1960 .

[36]  O. Krizanova,et al.  Influence of chlorpromazine on the replication of influenza virus in chick embryo cells. , 1982, Acta virologica.

[37]  S. Constantinescu,et al.  Antiviral effect of lithium chloride. , 1988, Virologie.

[38]  N. A. Kefalides,et al.  Lithium chloride restores host protein synthesis in herpes simplex virus-infected endothelial cells. , 1989, Biochemical and biophysical research communications.

[39]  Y. Nakaoka,et al.  The Photodynamic Action of Methylene Blue on the Ion Channels of Paramecium Causes Cell Damage , 1997, Photochemistry and photobiology.

[40]  D. Israelski,et al.  Toxoplasmic encephalitis in patients with AIDS. , 1988, Infectious disease clinics of North America.

[41]  A. Bonhomme,et al.  Involvement of calcium and calmodulin in Toxoplasma gondii tachyzoite invasion. , 1997, European journal of cell biology.

[42]  E. Damonte,et al.  Inhibition of arenavirus multiplication in vitro by phenotiazines. , 1996, Antiviral research.

[43]  T. Henriksen,et al.  TREATMENT OF DIFFUSE CUTANEOUS LEISHMANIASIS WITH CHLORPROMAZINE OINTMENT , 1983, The Lancet.

[44]  G. Nemerow,et al.  Infection of B lymphocytes by a human herpesvirus, Epstein-Barr virus, is blocked by calmodulin antagonists. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Webster,et al.  Rats, cats, people and parasites: the impact of latent toxoplasmosis on behaviour. , 2001, Microbes and infection.

[46]  V. Wunderlich,et al.  Antiviral effect of haloperidol on Rauscher murine leukemia virus. , 1980, Archiv fur Geschwulstforschung.